Aktie A3EVA9 ALGORAE PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Algorae Pharmaceuticals Limited

Aktien

A3EVA9

AU0000296022

1AI

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 05:12:46 08.05.2024 		% 5 Tage % 1. Jan.
0,011 AUD 0,00 % Intraday Chart für Algorae Pharmaceuticals Limited +10,00 % +10,00 %
08.03. Algorae Pharmaceuticals nähert sich dem Start der Drug Discovery Plattform MT
28.02. Algorae Pharmaceuticals Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Halbjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform
Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Algorae Pharmaceuticals Considers Combination Therapy for NTCELL Trial
Algorae Pharmaceuticals Limited Announces Change of Company Secretary
Algorae Pharmaceuticals, HL Pharma Partner to Develop Cannabinoid Compound Storage and AI Platform
Algorae Pharmaceuticals Secures Agreement with HL Pharma
Algorae, Monash University Collaborate on Pre-Clinical Studies for Cardiovascular Diseases Drug; Shares Plunge 8%
Algorae Joins CSIRO's Next Generation AI Graduate Program with Grant Funding Participation; Shares Jump 8%
Algorae Pharmaceuticals Enters Partnership for Developing Drug Discovery AI Platform
Algorae Pharmaceuticals Limited announced that it has received AUD 0.001125 million in funding
Living Cell Technologies Collaborating With La Trobe University for Dementia Drug Candidate
Living Cell Technologies Limited has Changed its Name to Algorae Pharmaceuticals Limited
Living Cell Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Living Cell Technologies Files Provisional Patent Application for CBD-Combination Drug Candidate for Dementia
Living Cell Technologies May Change Name to Algorae Pharmaceuticals; Shares Rise 6%
Living Cell Technologies Limited Announces Management Changes
Living Cell Technologies Appoints Chief Scientific Officer; Shares Jump 9%
Living Cell Technologies Limited Appoints James A Mckenna as Chief Scientific Officer
Living Cell Technologies Raises Additional Funds from Shortfall Offer
Living Cell Technologies Limited Announces Change of Registered Office
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EVA9 Aktie
  4. Nachrichten Algorae Pharmaceuticals Limited
  5. Andere Sprachen